View Article

Abstract

Cancer remains one of the leading global health challenges, characterized by uncontrolled cellular proliferation, genetic instability, and the potential for metastasis. cancers are broadly classified into carcinomas, sarcomas, leukemias, lymphomas, myelomas and mixed type cancer. The etiology of cancer involves a Multifactorial interplay between genetic mutations, environmental exposures, lifestyle factors, And infectious agents. Mutations in oncogenes and tumor suppressor genes, alongside chronic Exposure to carcinogens, initiate and promote malignant transformation. Preventive measures are categorized into primary, secondary, and tertiary levels, emphasizing lifestyle modification, Vaccination, early detection through screening, and post-treatment rehabilitation. Chemotherapy remains a cornerstone of cancer therapy, utilizing diverse drug classes such as alkylating agents, antimetabolites, mitotic inhibitors. Recent advances, Including immunotherapy, nanotechnology-based drug delivery, and precision oncology, have Revolutionized cancer management by enhancing selectivity and reducing systemic toxicity. Furthermore, gene-editing tools such as CRISPR/Cas9 and artificial intelligence applications in diagnostics signify promising future directions. Collectively, these multidisciplinary Approaches underscore the importance of integrating prevention, early diagnosis, and Personalized treatment to improve global cancer outcomes.

Keywords

Oncogenes, tumor suppressor genes, prevention strategies, chemotherapy, targeted therapy, precision oncology, CRISPR technology, nanomedicine

Introduction

Cancer: -

Cancer represents a group of diseases characterized by the abnormal and uncontrolled Proliferation of cells that invade and destroy surrounding tissues and can metastasize to distant Organs. According to the World Health Organization (WHO), Cancer remains one of the leading causes of death globally, responsible for nearly 10 million Deaths in 2022, accounting for one in six deaths worldwide [1]. The global burden of cancer continues to rise due to population aging, lifestyle changes, and exposure to carcinogenic factors. The most prevalent cancers include breast, lung, colorectal, and prostate cancers, with lung cancer being the leading cause of mortality [2]. Early diagnosis and effective treatment are crucial for improving survival outcomes, as most cancers exhibit better prognoses when detected in early stages. Cancer Can be classified according to various criteria, including histogenesis, tissue of origin, Molecular profile, and clinical behavior [3].

  1. Types of Cancer: -

Reference

  1. Sung H, et.al., “Global Cancer Statistics 2023”, CA Cancer J Clin,2023;73(1):17–54.
  2. Bray F, et.al., “Global cancer transition according to the Human Development Index”, Lancet Oncol, 2022;23(9):1224–36.
  3. Ferlay J, et. al., “Cancer incidence and mortality worldwide”, Int J Cancer, 2021;149(4):778–89.
  4. Torre LA, et.al., “Global Cancer Epidemiology”, CA Cancer J Clin, 2020;70(2):87–108.
  5. Kumar V, Abbas AK, Aster JC, “Robbins and Cotran Pathologic Basis of Disease”,10th Ed., Elsevier; 2021.
  6. Mertens F, et.al., “Sarcomas of soft tissue and bone: a review. Genes Chromosomes Cancer”, 2020;59(12):575–91.
  7. Coindre JM, “Grading of soft tissue sarcomas, Histopatholog”,2018;72(1):51–63.
  8. Rowley JD, “Chromosomal translocations in leukemia”, Nature, 2008;451(7178):849–56.
  9. Jabbour E,   Kantarjian          H,      “Chronic myeloid         leukemia:         2020    update”, Blood, 2020;135(5):387–99.
  10. Carbone A, Gloghini A, “The pathogenesis of Hodgkin lymphoma”, Blood Rev, 2021;48:100798.
  11. Kyle RA, Rajkumar SV, “Pathogenesis of multiple myeloma. Blood”, 2008;111(6):2962- 72.
  12. Ulbright TM, “Germ cell tumors of the gonads: a review”, Mod Pathol, 2020;33(S1): S36– S55.
  13. Levine AJ, “P53: 800 million years of evolution and 40 years of discovery”, Nat Rev Cancer, 2020;20(8):471–80.
  14. Brash DE, “UV signature mutations. Photochem Photobiol”, 2015;91(1):15–26.
  15. Loomis D, et.al., “The carcinogenicity of outdoor air pollution”, Lancet Oncol, 2013;14(13):1262–3.
  16. Islami F, et.al., “Global burden of cancer attributable to tobacco smoking”, CA Cancer J Clin, 2020;70(6):426–45.
  17. Friedenreich CM, et. al., “Physical activity and cancer prevention”, Br J Sports Med, 2021;55(13):763–70.
  18. Bray F, Jemal A, Grey N, Ferlay J, Forman D, “Global cancer transitions according to the Human Development Index (2008–2030)”, Lancet Oncol, 2012;13(8):790–801.
  19. Islami F, Torre LA, Jemal A, “Global trends of lung cancer mortality and smoking Prevalence”, Transl Lung Cancer Res, 2015;4(4):327–38.
  20. Key TJ, et.al.,       “Diet,        nutrition         and the prevention        of         cancer, Public Health Nutr.”,2004;7(1A):187–200.
  21. Boffetta P, Hashibe M, “Alcohol and cancer”, Lancet Oncol, 2006;7(2):149–56.
  22. Schiffman M, Castle PE, Jeronimo J, et.al., “Human papillomavirus and cervical cancer”, Lancet, 2007;370(9590):890–907.
  23. Arbyn M, et.al., “Worldwide burden of cervical cancer”, Vaccine, 2020;38(5):802–11.
  24. Myers ER,  et.al., “Benefits   and    harms   of breast           cancer  screening”,       JAMA, 2015;314(15):1615–34.
  25. Rex DK, et.al., “Colorectal cancer screening: recommendations for physicians And patients”, Am J Gastroenterol, 2017;112(7):1016–30.
  26. Moyer VA, “Screening for prostate cancer: U.S. Preventive Services Task Force Recommendation statement”, Ann Intern Med,2012;157(2):120–34.
  27. Aberle DR, et.al., “Reduced lung-cancer mortality with low-dose computed Tomographic screening”, N Engl J Med, 2011;365(5):395–409.
  28. Silver JK, et.al., “Cancer rehabilitation and survivorship care Cancer”, 2013;119(11 Suppl):2209–16.
  29. Temel JS, et.al., “Early palliative care for patients with metastatic non–small-cell Lung cancer”, N Engl J Med. 2010;363(8):733–42.
  30. Curigliano G, et.al., “Management of cancer treatment–related toxicities”, Ann Oncol, 2020;31(10):1312–24.
  31. Fisher B, et.al., “Surgical adjuvant therapy in breast cancer”, N Engl J Med, 1989;320(8):479–84.
  32. He J, et.al., “Surgical management of lung cancer”, J Thorac Dis, 2018;10(Suppl 7): S863– S876.
  33. Law WL, et al., “Laparoscopic colorectal resection: a comparison with open Surgery”, Ann Surg, 2007;245(1):1–7.
  34. Veronesi U, et. al., “Sentinel-node biopsy to avoid axillary dissection in breast Cancer with clinically negative lymph nodes”, Lancet Oncol, 2013;14(7):607–15.
  35. Delaney G, Jacob S, Featherstone C, Barton M, “The role of radiotherapy in Cancer treatment”, Cancer, 2005;104(6):1129–37.
  36. Bernier J, Hall EJ, Giaccia A, “Radiation oncology: a century of achievements”, Nat Rev Cancer,2004;4(9):737–47.
  37. Bentzen SM, “Preventing or reducing late side effects of radiation therapy”, Nat Rev Cancer, 2006;6(9):702–13.
  38. DeVita VT Jr, “Chu E. A history of cancer chemotherapy”, Cancer Res, 2008;68(21):8643– 53.
  39. Longley DB, Johnston PG, “Molecular mechanisms of drug resistance”, J Pathol, 2005;205(2):275–92.
  40. Burstein HJ, et.al., “Chemotherapy for advanced breast cancer”, J Clin Oncol, 2001;19(6):1671–87.
  41. Holohan C, et. al., “Cancer drug resistance: an evolving paradigm”, Nat Rev Cancer, 2013;13(10):714–26.
  42. Curigliano G, et.al., “Management of cancer treatment–related toxicities”, Ann Oncol, 2020;31(10):1312–24.
  43. Davis ME, Chen ZG, Shin DM, “Nanoparticle therapeutics: an emerging Treatment modality for cancer”, Nat Rev Drug Discov, 2008;7(9):771–82.
  44. Brock N, “Mesna and other thiols for prevention of urotoxicity of Oxazaphosphorine cytostatics”, Cancer Chemother Pharmacol, 1983;11(1):1–6.
  45. Jolivet J, et. al., “The pharmacology and clinical use of methotrexate”, N Engl J Med, 1983;309(18):1094–104.
  46. Tacar O, et.al., “Doxorubicin: an update on anticancer molecular action”, Cancer Treat Rev, 2013;40(4):473–88.
  47. Sleijfer S, “Bleomycin-induced pneumonitis”, Chest. 2001;120(2):617–24.
  48. Swain SM, Whaley FS, Ewer MS, “Congestive heart failure in patients treated with doxorubicin”, Cancer. 2003;97(11):2869–79.
  49. O’Sullivan JM, et.al., “Bleomycin pulmonary toxicity: clinical features and Management”, J Clin Oncol, 2003;21(5):913–26.
  50. Rowinsky EK, “Donehower RC, Paclitaxel and docetaxel in cancer therapy”, J Natl Cancer Inst., 1995;87(16):1265–79.
  51. Weaver BA, “How taxol/paclitaxel kills cancer cells”, Mol Biol Cell, 2014;25(18):2677– 81.
  52.  Siegel RL, Miller KD, Fuchs HE, Jemal A, “Cancer statistics, 2025”, CA Cancer J Clin, 2025;75(1):3–24.
  53. Shi J, Kantoff PW, Wooster R, Farokhzad OC, “Cancer nanomedicine: progress, Challenges and opportunities”, Nat Rev Cancer, 2017;17(1):20–37.
  54. Wang AZ, Langer R, Farokhzad OC, “Nanoparticle delivery of cancer drugs”, Anna Rev Med, 2012;63:185–98.
  55. Dienstmann R, Rodon J, Barretina J, Tabernero J, “Genomic medicine frontier in oncology”, Nat Rev Clin Oncol, 2013;10(9):535–49.
  56. Doble B, Chan CL, Toh CK, Ho BK, Soo RA, “Personalized medicine in Oncology: strategies and future directions”, Front Med, 2021;8:652–81.
  57. Rosenblum D, et. al., “Progress and challenges towards CRISPR-based cancer Therapies”, Nat Commun, 2020;11(1):1–11.
  58. Stadtmauer EA, et.al., “CRISPR-engineered T cells in patients with refractory Cancer”, Science, 2020;367(6481): eaba7365.
  59. Esteva A, et. al., “A guide to deep learning in healthcare”, Nat Med, 2019;25(1):24 – 9.
  60. Bibault JE, et.al., “Artificial intelligence in precision oncology: current Applications and future perspectives”, Cancer Lett, 2021;532:95–105.

Photo
Pallavi Ghankar
Corresponding author

Navsanjeevan Shikshan Mandal’s College of Pharmacy, Darwha, Dist-Yavatmal Maharashtra India

Photo
Anisha Bhowate
Co-author

Navsanjeevan Shikshan Mandal’s College of Pharmacy, Darwha, Dist-Yavatmal Maharashtra India

Photo
Tejaswini Tidke
Co-author

Navsanjeevan Shikshan Mandal’s College of Pharmacy, Darwha, Dist-Yavatmal Maharashtra India

Photo
Avinash Jiddewar
Co-author

Navsanjeevan Shikshan Mandal’s College of Pharmacy, Darwha, Dist-Yavatmal Maharashtra India

Pallavi Ghankar*, Anisha Bhowate, Tejaswini Tidke, Avinash Jiddewar, The Role of Medicine in Cancer with Emerging Trend and Future Perspective, Int. J. Sci. R. Tech., 2025, 2 (11), 671-683. https://doi.org/10.5281/zenodo.17720050

More related articles
Liquisolid Compacts: A Paradigm in Drug Delivery S...
Priya Patil, Dr. Bharat Tekade, Dr. Mohan Kale, ...
Applications Of Natural Zeolite Minerals In Cosmet...
Yashodhan Patil, Praful Shinde, Karuna Ghodki, ...
A Compressive Review of Remidies of Hyperthyroidis...
Roshan Rathod, Abhishek Waghmare, Pushpraj Vandekar, Harshad Nika...
A Comprehensive Review on Chikungunya Virus Epidemiology, Pathogenesis, Clinic...
Suraj Kedar, Prasad Harad, Bhavesh Mohape, Om Farde, Amin Shaikh, Manas Dandkar, Sarthak Bhusal, Nir...
Edge Detection Using Fuzzy C-Means: A Comparative Study...
S. K. Srimonishaa, Dr. Muthukumar P., ...
Related Articles
Comparative Analysis of the Efficiency and Safety of Pantoprazole, Omeprazole an...
Arnab Roy, Abhinav Kumar, Dr. K. Rajeswar Dutt, Astha Topno , Ayush Kumar, Sajid Ansari , Rajan Kuma...
Pharmacognostical and Phytochemical Evaluation of Benincasa Hispida...
F. Pincy Mol, Madhankumar R., Harish S., Sowmiya J. S., Reshma R. Nath, Asha A. S., ...
Liquisolid Compacts: A Paradigm in Drug Delivery System...
Priya Patil, Dr. Bharat Tekade, Dr. Mohan Kale, ...
More related articles
Liquisolid Compacts: A Paradigm in Drug Delivery System...
Priya Patil, Dr. Bharat Tekade, Dr. Mohan Kale, ...
Applications Of Natural Zeolite Minerals In Cosmetics...
Yashodhan Patil, Praful Shinde, Karuna Ghodki, ...
A Compressive Review of Remidies of Hyperthyroidism...
Roshan Rathod, Abhishek Waghmare, Pushpraj Vandekar, Harshad Nikam, Vanshika Pawar, Iram Maniyar, Ch...
Liquisolid Compacts: A Paradigm in Drug Delivery System...
Priya Patil, Dr. Bharat Tekade, Dr. Mohan Kale, ...
Applications Of Natural Zeolite Minerals In Cosmetics...
Yashodhan Patil, Praful Shinde, Karuna Ghodki, ...
A Compressive Review of Remidies of Hyperthyroidism...
Roshan Rathod, Abhishek Waghmare, Pushpraj Vandekar, Harshad Nikam, Vanshika Pawar, Iram Maniyar, Ch...